Caption Management’s Celularity CELU Stock Holding History

Caption Management’s Portfolio CELU Stock Details CELU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-2,000	Closed	-$142K	–	1628
2021 Q3	$142K	Buy	+2,000	New	+$161K	﹤0.01%	1382

Other funds holding CELU

SIC

Starr International Company Zug, Switzerland $19.9M AUM 39.69% 1-Year Est. Return

CVSC

C.V. Starr & Co New York $192M AUM 35.69% 1-Year Est. Return

Palantir Technologies Denver, Colorado $9.72M AUM 6.46% 1-Year Est. Return

LDFO

Louis-Dreyfus Family Office Wilton, Connecticut $64.7M AUM 21.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

LOAMU

Lombard Odier Asset Management (USA) New York $957M AUM 35.8% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

Caption Management's CELU Position: Q4 2021 in Review

Caption Management sold out of Celularity (CELU) in Q4 2021, closing a stake of 2,000 shares — an estimated $142K sold.

Caption Management first reported a position in CELU in Q3 2021 and held it in 1 quarter. The position peaked at $142K in Q3 2021. 24 funds tracked by Wall St. Rank hold CELU as of Q4 2021.

Caption Management reported no remaining Celularity position as of Q4 2021 after selling out during the quarter.
Caption Management sold 2,000 Celularity shares in Q4 2021, an estimated $142K.
Caption Management first reported a position in Celularity in Q3 2021 and held it in 1 quarter.
Caption Management's Celularity position peaked at $142K in Q3 2021.
24 funds tracked by Wall St. Rank held Celularity as of Q4 2021.

Based on Caption Management's 13F filing for Q4 2021, filed 11 Feb 2022.